Inhaled Cisplatin for NSCLC: Facts and Results

Although we have new diagnostic tools for non-small cell lung cancer, diagnosis is still made in advanced stages of the disease. However, novel treatments are being introduced in the market and new ones are being developed. Targeted therapies and immunotherapy have brought about a bloom in the treat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2019-04, Vol.20 (8), p.2005
Hauptverfasser:	Kosmidis, Christoforos, Sapalidis, Konstantinos, Zarogoulidis, Paul, Sardeli, Chrysanthi, Koulouris, Charilaos, Giannakidis, Dimitrios, Pavlidis, Efstathios, Katsaounis, Athanasios, Michalopoulos, Nikolaos, Mantalobas, Stylianos, Koimtzis, Georgios, Alexandrou, Vyron, Tsiouda, Theodora, Amaniti, Aikaterini, Kesisoglou, Issak
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Aerosols Alveoli Animals Antineoplastic Agents - administration & dosage Antineoplastic Agents - pharmacokinetics Antineoplastic Agents - therapeutic use Biological Availability Carcinoma, Non-Small-Cell Lung - drug therapy Chemotherapy Cisplatin Cisplatin - administration & dosage Cisplatin - pharmacokinetics Cisplatin - therapeutic use Cystic fibrosis Disease Drugs Epidermal growth factor Epidermal growth factor receptors Gene expression Growth factors Humans Humidity Immunotherapy Kinases Lung - drug effects Lung cancer Lung Neoplasms - drug therapy Lungs Lymphatic system Nebulizers and Vaporizers Non-small cell lung carcinoma Particle size Protein kinase Protein-tyrosine kinase Pulmonary circulation Respiratory diseases Review Tyrosine Ultrasonic imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!